LumiThera said March 3 that Diopsys is now a wholly-owned subsidiary. The acquisition is expected to create a complementary diagnosis and monitoring platform to LumiThera’s Valeda treatment platform.
The addition of Diopsys’ U.S. sales team will combine with LumiThera’s European Union sales team.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
